SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-016117
Filing Date
2022-08-09
Accepted
2022-08-09 16:31:58
Documents
67
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q avro-20220630.htm   iXBRL 10-Q 2481751
2 EX-10.3 avro-ex10_3.htm EX-10.3 313621
3 EX-31.1 avro-ex31_1.htm EX-31.1 19734
4 EX-31.2 avro-ex31_2.htm EX-31.2 19739
5 EX-32.1 avro-ex32_1.htm EX-32.1 17331
  Complete submission text file 0000950170-22-016117.txt   7633618

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT avro-20220630_cal.xml EX-101.CAL 32569
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT avro-20220630_def.xml EX-101.DEF 121436
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT avro-20220630_lab.xml EX-101.LAB 349571
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT avro-20220630_pre.xml EX-101.PRE 245455
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT avro-20220630.xsd EX-101.SCH 44038
61 EXTRACTED XBRL INSTANCE DOCUMENT avro-20220630_htm.xml XML 1167144
Mailing Address 100 TECHNOLOGY SQUARE 6TH FLOOR CAMBRIDGE MA 02139
Business Address 100 TECHNOLOGY SQUARE 6TH FLOOR CAMBRIDGE MA 02139 617.914.8420
AVROBIO, Inc. (Filer) CIK: 0001681087 (see all company filings)

IRS No.: 810710585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38537 | Film No.: 221148850
SIC: 2836 Biological Products, (No Diagnostic Substances)